393 related articles for article (PubMed ID: 7312007)
1. Effects of estrogens and progestins on the biochemistry and morphology of the postmenopausal endometrium.
Whitehead MI; Townsend PT; Pryse-Davies J; Ryder TA; King RJ
N Engl J Med; 1981 Dec; 305(27):1599-605. PubMed ID: 7312007
[TBL] [Abstract][Full Text] [Related]
2. Effects of various types and dosages of progestogens on the postmenopausal endometrium.
Whitehead MI; Townsend PT; Pryse-Davies J; Ryder T; Lane G; Siddle NC; King RJ
J Reprod Med; 1982 Aug; 27(8 Suppl):539-48. PubMed ID: 7131447
[No Abstract] [Full Text] [Related]
3. The role of estradiol dehydrogenase in mediating progestin effects on endometrium from postmenopausal women receiving estrogens and progestins.
King RJ; Townsend PT; Whitehead MI
J Steroid Biochem; 1981 Mar; 14(3):235-8. PubMed ID: 6261039
[No Abstract] [Full Text] [Related]
4. Assessment of oestrogen and progestin effects on epithelium and stroma from pre- and postmenopausal endometria.
King RJ; Lane G; Siddle N; Taylor RW; Townsend PT; Whitehead MI
J Steroid Biochem; 1981 Dec; 15():175-81. PubMed ID: 7339244
[TBL] [Abstract][Full Text] [Related]
5. Simple biochemical method to assess progestin effects on human endometrial DNA synthesis and its application to endometrial carcinoma.
King RJ; Raju KS; Siddle NC; Taylor RW; Whitehead MI
Cancer Res; 1983 Oct; 43(10):5033-6. PubMed ID: 6883350
[TBL] [Abstract][Full Text] [Related]
6. Actions of progestins on the morphology and biochemistry of the endometrium of postmenopausal women receiving low-dose estrogen therapy.
Whitehead MI; Townsend PT; Pryse-Davies J; Ryder T; Lane G; Siddle N; King RJ
Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):791-5. PubMed ID: 6278933
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the potency of orally administered progestins in women.
King RJ; Whitehead MI
Fertil Steril; 1986 Dec; 46(6):1062-6. PubMed ID: 2946605
[TBL] [Abstract][Full Text] [Related]
8. Dose-dependent effects of synthetic progestins on the biochemistry of the estrogenized post-menopausal endometrium.
Siddle NC; Townsend PT; Young O; Minardi J; King RJ; Whitehead MI
Acta Obstet Gynecol Scand Suppl; 1981; 106():17-22. PubMed ID: 6281330
[TBL] [Abstract][Full Text] [Related]
9. Biochemical studies on endometrium from postmenopausal women receiving hormone replacement therapy.
King RJ; Whitehead MI; Campbell S; Minardi J
Postgrad Med J; 1978; 54 Suppl 2():65-8. PubMed ID: 216982
[TBL] [Abstract][Full Text] [Related]
10. Effect of estrogen and progestin treatments on endometria from postmenopausal women.
King RJ; Whitehead MI; Campbell S; Minardi J
Cancer Res; 1979 Mar; 39(3):1094-101. PubMed ID: 427751
[TBL] [Abstract][Full Text] [Related]
11. Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
Varma TR
Acta Obstet Gynecol Scand; 1985; 64(1):41-6. PubMed ID: 2983513
[TBL] [Abstract][Full Text] [Related]
12. Biochemical analyses of separated epithelium and stroma from endometria of premenopausal and postmenopausal women receiving estrogen and progestins.
King RJ; Townsend PT; Whitehead MI; Young O; Taylor RW
J Steroid Biochem; 1981 Oct; 14(10):979-87. PubMed ID: 7300331
[No Abstract] [Full Text] [Related]
13. Use of progestins.
Mishell DR
Postgrad Med; 1989 Apr; Spec No():84-8; discussion 89-90. PubMed ID: 2542913
[TBL] [Abstract][Full Text] [Related]
14. A simple method for determining the optimal dosage of progestin in postmenopausal women receiving estrogens.
Padwick ML; Pryse-Davies J; Whitehead MI
N Engl J Med; 1986 Oct; 315(15):930-4. PubMed ID: 3762595
[TBL] [Abstract][Full Text] [Related]
15. Effects of progestins of human proliferative endometrium: an in vitro model of potential clinical relevance.
Illouz S; Dales JP; Sferlazzo K; Garcia S; Carpentier-Meunier S; Boubli L; Lavaut MN; Charpin C
Int J Mol Med; 2003 Oct; 12(4):517-23. PubMed ID: 12964029
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
17. Is Provera the ideal progestogen for addition to postmenopausal estrogen therapy?
Lane G; Siddle NC; Ryder TA; Pryse-Davies J; King RJ; Whitehead MI
Fertil Steril; 1986 Mar; 45(3):345-52. PubMed ID: 3005052
[TBL] [Abstract][Full Text] [Related]
18. Induction of human endometrial estradiol dehydrogenase by progestins.
Tseng L; Gurpide E
Endocrinology; 1975 Oct; 97(4):825-33. PubMed ID: 172318
[TBL] [Abstract][Full Text] [Related]
19. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
20. Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol.
Wahl P; Walden C; Knopp R; Hoover J; Wallace R; Heiss G; Rifkind B
N Engl J Med; 1983 Apr; 308(15):862-7. PubMed ID: 6572785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
